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Abstract Apoptosis is a highly regulated form of programmed
cell death crucial for life and health in metazoan animals.
Apoptosis is defined by a set of cytological alterations. The
recent discovery of these markers in yeast indicates the presence
of the basic mechanisms of apoptosis already in unicellular
eukaryotes. Oxygen radicals regulate both mammalian and yeast
apoptosis. We suggest that apoptosis originated in unicellular
organisms as an altruistic response to severe oxidative damage.
Later, cells developed mechanisms to purposely produce reactive
oxygen species as a regulator of apoptosis. Yeast may become an
important model to investigate the conserved steps of apoptosis.
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1. Introduction
Apoptosis has been de¢ned as a highly regulated form of
programmed cell death in metazoan animals resulting in the
removal of mutated, infected or simply dispensable cells.
While accidental cell death (necrosis) is usually accompanied
by cell breakage and neighbouring in£ammation, apoptosis
avoids rupture of the dying cell, preventing spillage of cell
contents.
The term apoptosis was coined by Kerr, Wyllie and Currie
[1] in the early 1970s. They also described characteristic events
which are still used today to recognise apoptosis such as chro-
matin condensation, nuclear fragmentation and formation of
apoptotic bodies. Nevertheless, there was little research on the
subject in the following years.
When its crucial role in development, homeostasis, and the
prevention and the promotion of di¡erent diseases was recog-
nised, apoptosis suddenly became a hot topic. Failure of
apoptosis can result in cancer, autoimmune diseases and
spreading of viral infections, while neurodegenerative disor-
ders, AIDS and ischaemic diseases are caused or enhanced by
apoptosis [2].
Apoptosis has been found throughout the animal kingdom.
In vertebrates, it is controlled by a complex regulatory net-
work which can be activated by toxins or external signals (e.g.
ethanol, reactive oxygen species (ROS), receptor ligands) and
internal processes (e.g. mitotic catastrophe, replication failures
or developmental programmed cell death). Regulatory path-
ways and inducers vary depending on tissue, developmental
state, or host organism, resulting in diverse and sometimes
contradictory models for the regulation of apoptosis. The reg-
ulatory mechanism seems to be simpler in Caenorhabditis el-
egans or Drosophila melanogaster [2].
Despite these di¡erences, the late events of apoptosis down-
stream of the complex regulatory network seem to be shared
between all metazoan animals as many of the typical markers,
DNA fragmentation, chromatin condensation, membrane
blebbing, externalisation of phosphatidylserine and formation
of apoptotic bodies, can be observed in most cases of apopto-
sis. The mechanisms directly responsible for these features are
poorly understood [3].
2. Is yeast a suitable model for investigation of metazoan
apoptosis?
Yeast comprises a phylogenetically heterogeneous group of
ascomycetic fungi. Two yeast species, Saccharomyces cerevisi-
ae and Schizosaccharomyces pombe, have been investigated
intensively as they have simple, well understood genetics and
are amenable to modi¢cation by gene technology. They serve
as simple yet powerful models of common eukaryotic pro-
cesses such as cell division or intracellular transport. For
apoptosis research however, yeasts have not appeared to be
suitable model organisms. Being monocellular, a suicide pro-
gramme would not seem to o¡er the advantage inherent in
multicellular systems. In addition, the complete genomic se-
quence of S. cerevisiae lacks any obvious homologue of major
apoptotic regulators described in metazoan organisms (bax/
bcl-2 family, caspases, Apaf-1/CED-4, p53).
3. Apoptotic genes kill yeast
Therefore, yeast was used as a ‘clean room’ system to study
interactions between heterologously expressed components of
apoptotic pathways. Unexpectedly, expression of some apo-
ptotic inducers such as Bax [4^6], caspases [7,8], p53 [9,10], or
CED-4/Apaf-1 [11] resulted in cell death of the yeast host in
both S. cerevisiae and S. pombe. Simultaneous expression of
Bcl-2 or Bcl-xL which inhibit apoptosis in animals prevented
Bax-induced cell death [4^6,12]. In animals, Bax or Bak pro-
teins are not cytotoxic per se, as inhibition of the caspases
acting downstream of Bax can prevent cell death [13]. There-
fore, bax-induced death of yeast cells seems not to be the
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result of simple cytotoxicity, but is rather caused by the acti-
vation of some sort of death programme. In fact, the struc-
tural requirements for proteins of the bax/bcl-2 family for
killing or rescuing appear to be the same in animals and yeast.
The dimerisation-mediating BH3 domain of Bax and its tar-
geting to mitochondrial membranes are both essential for kill-
ing mammalian as well as yeast cells [14]. Furthermore, mu-
tant forms of Bcl-xL, an anti-apoptotic Bcl-2 family member,
lacking Bax binding activity can prevent Bax-induced death in
yeast [15,16]. This indicates that Bcl-xL acts downstream of
Bax, perhaps by competing for binding to a common target,
which may be part of the conserved apoptotic machinery.
While these results suggest similar mechanisms for the
downstream events of bax-induced cell death in yeast and
animals, some reports indicate that the morphological features
of death di¡er. S. pombe cells expressing bax show no DNA
laddering and no shrinkage of the cell. Cell death in S. pombe
is neither accompanied by caspase-like activities, nor can it be
prevented by caspase inhibitors [12]. However, other research-
ers report a chromatin condensation accompanying the ex-
pression of bax [17] or of CED-4 (Apaf-1, [11]) as an indica-
tion of apoptosis. They also observe as a result of bax
expression in S. pombe the formation of a large DNA frag-
ment, derived from genomic DNA, but no DNA ladder, thus
showing the occurrence of DNA cleavage. Furthermore, Zhao
et al. [18] observed the typical margination of chromatin
against the nuclear envelope in S. pombe killed by the expres-
sion of pro-apoptotic HIV-1 Vpr protein.
In bax-expressing S. cerevisiae, even more markers of apo-
ptosis have been detected. Cells show margination of chroma-
tin at the nuclear envelope, extensive DNA cleavage demon-
strated by the TUNEL test, membrane blebbing, and
externalisation of phosphatidylserine at the cytoplasmic mem-
brane. Simultaneous expression of Bcl-xL prevents these
e¡ects [19].
4. Intrinsically triggered apoptosis in yeast
All previously described examples of yeast apoptotic cell
death involved heterologous gene expression. In 1997, we
found that a point-mutated CDC48 (cdc48S565G), a S. cerevi-
siae gene belonging to the AAA family and involved in ho-
motypic membrane fusion, results in cells dying with a typical
apoptotic phenotype: exposition of phosphatidylserine, mar-
gination of chromatin, DNA fragmentation and formation of
cell fragments [20]. In spite of massive DNA breakage, dem-
onstrated by the TUNEL test, no DNA ladder could be ob-
served. Nucleosome linkers appear not to be preferred targets
of DNA cleavage in yeast, probably due to their short length
[21].
The co-ordinate occurrence of these events at di¡erent lo-
cations within the cell having no obvious connection except
their relation to apoptosis indicates the presence of a machi-
nery performing the basic steps of apoptosis already in yeast.
5. Programmed cell death in other monocellular eukaryotes
Yeast is not the only or even the ¢rst monocellular eukary-
ote for which programmed cell death has been described.
Trypanosoma cruzi and T. brucei rhodesiense, Dictyostelium
discoideum, and Tetrahymena thermophila show some apopto-
tic features such as cytoplasmic blebbing and vacuolisation,
DNA fragmentation and chromatin condensation in response
to environmental stress or extracellular signals [22]. These
organisms are evolutionarily more distant from mammals
than yeast is, dating the origin of programmed cell death
yet further back in evolution. Indeed, higher plants, which
are about as closely related to mammals as yeast is, exhibit
characteristic apoptotic features, such as DNA strand breaks
and exposition of phosphatidylserine [23], and can be pro-
tected from cell death by expression of the anti-apoptotic
genes, bcl-xL or ced-9 [24].
6. ROS are endogenous regulators of apoptosis in yeast
As the basic apoptotic machinery seems to be present in
yeast, the question arises how the apoptotic programme is
regulated when all crucial regulator genes known from the
mammalian system are missing.
However, regulators of apoptosis exist which are not pro-
teins and therefore cannot be deduced from the genomic se-
quence. ROS (such as O32 , H2O2 and OH
) are a well char-
acterised class of apoptotic inducers. Intracellular ROS
accumulate in neural cells deprived of nerve growth factor
or potassium as a late step of the apoptotic pathway, down-
stream of the action of bax and caspases [25,26]. This accu-
mulation is a prerequisite for the ensuing cell death. In addi-
tion, exogenous oxygen stress triggers the apoptotic cascade
by itself [27^30].
In S. cerevisiae, exposure to low doses of H2O2 or accumu-
lation of ROS by depletion of glutathione induces apoptosis
as well. Inhibition of translation by cycloheximide prevents
the development of apoptotic markers in response to H2O2,
indicating an active role of the cell in the death process [31].
Furthermore, yeast cell death caused by the expression of bax
or by cdc48S565G is accompanied by an accumulation of ROS.
Indeed, these radicals are necessary to induce the apoptotic
phenotype [31], putting ROS at a central position in yeast
apoptosis.
7. A potential scenario for the development of apoptosis
This important role of ROS in the regulation of apoptosis
may indicate the origin and primary purpose of the suicide
process. ROS are byproducts of respiration and occur in every
aerobic organism. Because ROS are highly reactive and mod-
ify proteins, lipids and nucleic acids, ROS-induced cell dam-
age is a frequent event. In cases of potentially fatal damage,
rapid suicide will terminate the now futile metabolism of the
cell. For a unicellular organism this spares nutrient resources
for the surrounding cells ^ usually cells of its own clone. Its
suicide will be of advantage for its clonal relatives ^ and there-
fore for the genome of the damaged individual itself. High
concentrations of ROS serve as the trigger of the process,
possibly because their chemical reactivity made them easy to
detect.
In the further development of apoptosis, a suicide mecha-
nism may have proved useful for additional purposes as well.
A potential case of cellular suicide in yeast has been described
by Longo et al. [32] who observed that stationary cells of S.
cerevisiae survive for long periods in pure water but quickly
lose viability in nutrient-depleted synthetic media. Death of a
majority of cells may spare the dwindling resources for the
best adapted, healthiest, or ^ as yeast has a ¢nite lifespan ^
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youngest isogenic relatives. Production of ROS as an endog-
enous signal to trigger the suicide programme autonomously
became desirable. As oxygen radicals are normal byproducts
of respiration, a speci¢c modulation of the respiratory chain
may have been developed to increase the output of ROS as
needed. The release of cytochrome c may be a result of that
modulation. ‘Petite’ yeasts lacking functional mitochondria
survive bax expression [6] consistent with the necessity of an
active respiratory chain in the suicide mechanism.
During a further re¢nement in the regulation of apoptosis,
released cytochrome c itself became used as an apoptotic sig-
nal, perhaps in order to make the regulatory cascade less de-
pendent on the redox state of the cell. With the development
of multicellular organisms, a more £exible regulation of apo-
ptosis became necessary, including responses to various exter-
nal signals, resulting in additional regulatory steps upstream,
downstream, or instead of ROS.
Recent observations concerning programmed cell death in
the dino£agellate Peridinium gatunense support this hypothe-
sis. Cell death is induced by oxidative stress [33], con¢rming
the evolutionarily ancient link between ROS and cell suicide.
P. gatunense exhibits typical markers of apoptosis, DNA frag-
mentation and protoplast shrinkage. A cysteine protease in-
hibitor prevents cell death indicating that a protease partici-
pates in the suicide programme, similar to the situation in
higher animals.
8. A comparison of cell death between yeast and mammals
Is it really apoptosis that has been observed in yeast? If
apoptosis is de¢ned as autonomous cell death in connection
with certain morphological and cytological markers, yeast cer-
tainly performs apoptosis (Fig. 1). If the de¢nition demands
the involvement of speci¢c proteins such as caspases or bcl-2
relatives, yeast does not. However, the similar response of
yeast and animals to oxygen stress and to the expression of
several pro- and anti-apoptotic genes argues strongly in fa-
vour of a common origin of the processes.
Yeast has already shown its value as a model for apoptosis
research (for review, see [34].) Reed and coworkers used the
cytotoxicity of bax on S. cerevisiae to select anti-apoptotic
e¡ectors from a human gene library [35] and to identify yeast
mutations preventing cell death [36]. Both strategies were suc-
cessful, and the results could be extended to mammalian
apoptosis. A mutated gene preventing yeast cell death was
identi¢ed as mitochondrial F0F1-ATPase. Inhibition of the
enzyme by oligomycin prevents cell death in both S. cerevisiae
and mammalian cells [36]. A novel anti-apoptotic factor, BI-1,
Fig. 1. Cytological markers of apoptosis in yeast and mammalian cells. S. cerevisiae treated with 1 mM H2O2 (A, B, C, I) or mutated in
CDC48 (cdc48S565G, D), porcine thyrocytes treated with 30 WM retinol (E, F, H, J), and human WISH cells treated with 1 mM H2O2 (G)
stained for chromatin with DAPI (A, B) or bisbenzimide (E, F), for DNA fragmentation with the TUNEL assay (C, G), for the exposition of
phosphatidylserine with FITC-labelled annexin V (D, H), or investigated by electron microscopy for chromatin condensation (I, J). Bars 10 Wm
(A^H), 1 Wm (I, J).
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was identi¢ed which is located at the endoplasmic reticulum
and interacts with Bcl-2, but not Bax or Bak. When overex-
pressed in mammalian cells, it suppresses apoptosis induced
by Bax, growth factor withdrawal or various drugs, but not
by Fas [35]. Additional anti-apoptotic genes functional in
yeast and mammals have been identi¢ed by a similar ap-
proach [37]. Recently, an anti-apoptotic function of the mam-
malian CDC48 orthologue VCP has been described [38], con-
¢rming the e¡ects of the cdc48S565G mutation in yeast as bona
¢de apoptosis.
In the near future, yeast promises the identi¢cation of com-
ponents of the basic, evolutionarily ancient stages of apopto-
sis. Yeast o¡ers the opportunity to easily screen for substances
acting directly on these basic components without being di-
verted by a complex upstream network. This may result in
‘universal’ activators or inhibitors of apoptosis which would
be helpful for research, and potentially for medical applica-
tions as well.
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